Teisuke Takahashi Selected Research

Teisuke Takahashi Research Topics

Disease

3	Fibrosis (Cirrhosis) 08/2022 - 06/2013
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 06/2013
3	Anemia 01/2021 - 11/2018
3	Reperfusion Injury 01/2009 - 01/2003
2	Hyperphosphatemia 01/2022 - 01/2022
2	Hypertension (High Blood Pressure) 01/2021 - 01/2020
2	Hypoxia (Hypoxemia) 01/2021 - 11/2018
2	Chronic Renal Insufficiency 01/2020 - 11/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2016 - 04/2010
2	Proteinuria 07/2015 - 06/2013
2	Hyperglycemia 07/2015 - 06/2013
1	Inflammation (Inflammations) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Diabetes Complications 01/2016
1	Necrosis 06/2013
1	Parkinson Disease (Parkinson's Disease) 12/2011
1	Neuroblastoma 08/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2011
1	Myocardial Stunning (Stunned Myocardium) 11/2004
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2003
1	Ventricular Fibrillation 01/2003

Drug/Important Bio-Agent (IBA)

4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2016 - 04/2010
3	SodiumIBA 01/2022 - 04/2010
3	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2021 - 11/2018
3	Erythropoietin FDA Link 01/2021 - 11/2018
3	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2016 - 06/2013
3	SEA 0400IBA 12/2011 - 01/2003
2	Carrier Proteins (Binding Protein)IBA 01/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 01/2022 - 06/2013
2	Phosphates (Orthophosphate)IBA 01/2022 - 01/2022
2	TP0463518IBA 01/2021 - 11/2018
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 11/2018
2	SaltsIBA 01/2020 - 07/2015
2	Lisinopril (Prinivil)FDA LinkGeneric 07/2015 - 06/2013
2	Sodium-Calcium ExchangerIBA 08/2011 - 01/2003
2	PhenetidineIBA 11/2004 - 01/2003
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2022
1	Antihypertensive Agents (Antihypertensives)IBA 08/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2022
1	IronIBA 01/2021
1	lysophosphatidic acidIBA 01/2021
1	3- (4- (4- ((1- (2- chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acidIBA 01/2021
1	LipidsIBA 01/2021
1	Peptidoglycan (Murein)IBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Lysophosphatidic Acid ReceptorsIBA 01/2021
1	Prolyl-Hydroxylase InhibitorsIBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 07/2015
1	Insulin (Novolin)FDA Link 06/2013
1	Sodium-Glucose Transport ProteinsIBA 06/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 12/2011
1	Proteins (Proteins, Gene)FDA Link 08/2011
1	p38 Mitogen-Activated Protein KinasesIBA 08/2011
1	SB 203580IBA 08/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2011
1	Phosphotransferases (Kinase)IBA 08/2011
1	U 0126 (UO 126)IBA 08/2011
1	MitogensIBA 08/2011
1	JNK Mitogen-Activated Protein KinasesIBA 08/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2011
1	Glucose (Dextrose)FDA LinkGeneric 04/2010
1	Sorbitol (Yal)FDA Link 04/2010
1	Dinoprostone (PGE2)FDA Link 01/2009

Therapy/Procedure

1	Therapeutics 06/2013